Without systematic assessment of molecular markers, the cohort analyzed on this study likely represents a heterogenous mixture of true IDH-wt astrocytomas and unrecognized molecular IDH-wt glioblastomas. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).